In TNBC, tumor cell-derived conditioned medium induces a polarized morphology and activation of neutrophils, mediated by cytokines such as TGF-β and the ligands for the chemokine receptor CXCR2, i.e., CXCL1/2/3 [23, 24]. The gene discussed is TGFB1; the disease is neoplasm.